The insurance sector index’s recent rally provides tailwinds for MetLife stock price forecast updates, pushing consensus price targets above the prior $70 ceiling. On February 19, Wells Fargo analyst Elyse Greenspan raised the price target on MET from $92 to $97, keeping an Overweight rating on the shares. The company’s solid 2024 results and history of strong returns on equity reflect its ability to execute growth strategies across different markets. With the latest growth strategy on the line, MET seems a promising insurance stock to buy now. Diversified portfolio lowers concentration risk: Given the nature of the business, multiline insurers’ product and service portfolios are diversified. This lowers concentration risk. Increased awareness, driving higher demand for protection products, should benefit sales and premiums of life insurance operations. An increase in exposure, with customized products and services, should support premium growth. Analysts tracking MetLife Inc. note that the current MetLife stock price forecast for Q3 2024 ranges between $68 and $73, driven by steady life insurance premium growth and resilient investment income streams. Trading volumes have held above the 30-day average, signaling healthy investor interest.